{"pmid":32418213,"title":"Reproductive health paradigms in times of COVID-19.","text":["Reproductive health paradigms in times of COVID-19.","For the past several months, we have witnessed one of the greatest global health challenges experienced by humankind. This unprecedented COVID-19 viral pandemic, characterized by its enigmatic nature and bewildering spread, respects no borders and has nearly paralyzed healthcare systems throughout the world. Indeed, in the absence of specific, proven medical interventions, healthcare systems have been overwhelmed, thus limiting their ability to treat patients with non-emergent medical conditions and those awaiting elective procedures. Although it is beyond the scope of this editorial to discuss what constitutes a necessary or elective procedure, this radical change in medical practice has had an enormous impact on discontinuation of fertility care services, especially the assisted reproductive technologies (ART). It is eminently clear that reducing or discontinuing elective procedures and essential ART treatments was crucial not only to enable hospitals and medical facilities to manage (or to treat) the explosive rise in SARS-CoV-2 patients, but also to reduce disease transmission vis-a-vis various mitigating strategies-especially individual isolation and social distancing, strategies utilized effectively in China and Italy.","Int J Gynaecol Obstet","David, Adamson","Zev, Rosenwaks","Van Der Spuy, Zephne","Diaz Yamal, Ivonne","32418213"],"abstract":["For the past several months, we have witnessed one of the greatest global health challenges experienced by humankind. This unprecedented COVID-19 viral pandemic, characterized by its enigmatic nature and bewildering spread, respects no borders and has nearly paralyzed healthcare systems throughout the world. Indeed, in the absence of specific, proven medical interventions, healthcare systems have been overwhelmed, thus limiting their ability to treat patients with non-emergent medical conditions and those awaiting elective procedures. Although it is beyond the scope of this editorial to discuss what constitutes a necessary or elective procedure, this radical change in medical practice has had an enormous impact on discontinuation of fertility care services, especially the assisted reproductive technologies (ART). It is eminently clear that reducing or discontinuing elective procedures and essential ART treatments was crucial not only to enable hospitals and medical facilities to manage (or to treat) the explosive rise in SARS-CoV-2 patients, but also to reduce disease transmission vis-a-vis various mitigating strategies-especially individual isolation and social distancing, strategies utilized effectively in China and Italy."],"journal":"Int J Gynaecol Obstet","authors":["David, Adamson","Zev, Rosenwaks","Van Der Spuy, Zephne","Diaz Yamal, Ivonne"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32418213","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/ijgo.13231","locations":["China","Italy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1667058206771249153,"score":9.490897,"similar":[{"pmid":32354663,"pmcid":"PMC7141636","title":"COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine.","text":["COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine.","The COVID-19 pandemic is an unprecedented global situation. As assisted reproductive technology (ART) specialists, we should be cautious, carefully monitoring the situation while contributing by sharing novel evidence to counsel our patients, both pregnant women and would-be mothers. Time to egg collection and drop-out rates are critical parameters for scheduling treatments once the curve of infections has peaked and plateaued in each country. In order to reduce the values for these two parameters, infertile patients now require even more support from their IVF team: urgent oocyte collection for oncology patients must be guaranteed, and oocyte retrievals for women of advanced maternal age and/or reduced ovarian reserve cannot be postponed indefinitely. This document represents the position of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) in outlining ART priorities during and after this emergency.","Reprod Biomed Online","Vaiarelli, Alberto","Bulletti, Carlo","Cimadomo, Danilo","Borini, Andrea","Alviggi, Carlo","Ajossa, Silvia","Anserini, Paola","Gennarelli, Gianluca","Guido, Maurizio","Levi-Setti, Paolo E","Palagiano, Antonio","Palermo, Roberto","Savasi, Valeria","Pellicer, Antonio","Rienzi, Laura","Ubaldi, Filippo M","32354663"],"abstract":["The COVID-19 pandemic is an unprecedented global situation. As assisted reproductive technology (ART) specialists, we should be cautious, carefully monitoring the situation while contributing by sharing novel evidence to counsel our patients, both pregnant women and would-be mothers. Time to egg collection and drop-out rates are critical parameters for scheduling treatments once the curve of infections has peaked and plateaued in each country. In order to reduce the values for these two parameters, infertile patients now require even more support from their IVF team: urgent oocyte collection for oncology patients must be guaranteed, and oocyte retrievals for women of advanced maternal age and/or reduced ovarian reserve cannot be postponed indefinitely. This document represents the position of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) in outlining ART priorities during and after this emergency."],"journal":"Reprod Biomed Online","authors":["Vaiarelli, Alberto","Bulletti, Carlo","Cimadomo, Danilo","Borini, Andrea","Alviggi, Carlo","Ajossa, Silvia","Anserini, Paola","Gennarelli, Gianluca","Guido, Maurizio","Levi-Setti, Paolo E","Palagiano, Antonio","Palermo, Roberto","Savasi, Valeria","Pellicer, Antonio","Rienzi, Laura","Ubaldi, Filippo M"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32354663","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.rbmo.2020.04.003","keywords":["advanced maternal age","covid-19","oncology patients","poor-prognosis patients","reduced ovarian reserve","sars-cov-2"],"topics":["Prevention"],"weight":1,"_version_":1666138495267110912,"score":198.05101},{"pmid":32404170,"title":"COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management.","text":["COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management.","The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. By contrast, the total number of COVID-19 deaths reported so far represents approximately 1.0% of the total deaths expected to occur worldwide over the first three months of the current year. It seems, therefore, that the number of infants expected to be conceived and born -but who will not be so due to the lockdown of infertility services- might be as significant as the total number of deaths attributed to the COVID-19 pandemic. We herein propose remedies that include a prognostic-stratification of more vulnerable infertility cases in order to plan a progressive restart of worldwide fertility treatments. At a time when preventing complications and limiting burdens for national health systems represent relevant issues, our viewpoint might help competent authorities and health care providers to identify patients who should be prioritized for the continuation of fertility care in a safe environment.","Reprod Biol Endocrinol","Alviggi, Carlo","Esteves, Sandro C","Orvieto, Raoul","Conforti, Alessandro","La Marca, Antonio","Fischer, Robert","Andersen, Claus Y","Buhler, Klaus","Sunkara, Sesh K","Polyzos, Nikolaos P","Strina, Ida","Carbone, Luigi","Bento, Fabiola C","Galliano, Daniela","Yarali, Hakan","Vuong, Lan N","Grynberg, Michael","Drakopoulos, Panagiotis","Xavier, Pedro","Llacer, Joaquin","Neuspiller, Fernando","Horton, Marcos","Roque, Matheus","Papanikolaou, Evangelos","Banker, Manish","Dahan, Michael H","Foong, Shu","Tournaye, Herman","Blockeel, Christophe","Vaiarelli, Alberto","Humaidan, Peter","Ubaldi, Filippo M","32404170"],"abstract":["The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. By contrast, the total number of COVID-19 deaths reported so far represents approximately 1.0% of the total deaths expected to occur worldwide over the first three months of the current year. It seems, therefore, that the number of infants expected to be conceived and born -but who will not be so due to the lockdown of infertility services- might be as significant as the total number of deaths attributed to the COVID-19 pandemic. We herein propose remedies that include a prognostic-stratification of more vulnerable infertility cases in order to plan a progressive restart of worldwide fertility treatments. At a time when preventing complications and limiting burdens for national health systems represent relevant issues, our viewpoint might help competent authorities and health care providers to identify patients who should be prioritized for the continuation of fertility care in a safe environment."],"journal":"Reprod Biol Endocrinol","authors":["Alviggi, Carlo","Esteves, Sandro C","Orvieto, Raoul","Conforti, Alessandro","La Marca, Antonio","Fischer, Robert","Andersen, Claus Y","Buhler, Klaus","Sunkara, Sesh K","Polyzos, Nikolaos P","Strina, Ida","Carbone, Luigi","Bento, Fabiola C","Galliano, Daniela","Yarali, Hakan","Vuong, Lan N","Grynberg, Michael","Drakopoulos, Panagiotis","Xavier, Pedro","Llacer, Joaquin","Neuspiller, Fernando","Horton, Marcos","Roque, Matheus","Papanikolaou, Evangelos","Banker, Manish","Dahan, Michael H","Foong, Shu","Tournaye, Herman","Blockeel, Christophe","Vaiarelli, Alberto","Humaidan, Peter","Ubaldi, Filippo M"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404170","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1186/s12958-020-00605-z","keywords":["assisted reproductive technology","covid-19","in vitro fertilization","infertility","intracytoplasmic sperm injection","poseidon criteria","viewpoint"],"topics":["Prevention"],"weight":1,"_version_":1666802845568991232,"score":194.70383},{"pmid":32238177,"pmcid":"PMC7112750","title":"Emerging infectious diseases and outbreaks: implications for women's reproductive health and rights in resource-poor settings.","text":["Emerging infectious diseases and outbreaks: implications for women's reproductive health and rights in resource-poor settings.","This century is witnessing dramatic changes in the health needs of the world's populations. The double burden of infectious and chronic diseases constitutes major causes of morbidity and mortality. Over the last two decades, there has been a rise in infectious diseases, including the severe acute respiratory syndrome virus (SARS), the H1N1 pandemic influenza, the Ebolavirus and the Covid-19 virus. These diseases have rapidly spread across the world and have reminded us of the unprecedented connectivity that defines our modern civilization. Though some countries have made substantial progress toward improving global surveillance for emerging infectious diseases (EIDs), the vast majority of Low-and Middle-income Countries (LMICs) with fragile health systems and various system-related bottlenecks remain vulnerable to outbreaks and, as such, experience dramatic social and economic consequences when they are reported. Lessons learned from past outbreaks suggest that gender inequalities are common across a range of health issues relating to Sexual and Reproductive Health and Rights (SRHR), with women being particularly disadvantaged, partially due to the burden placed on them. Though these countries are striving to improve their health systems and be more inclusive to this vulnerable group, the national/ global outbreaks have burdened the overall system and thus paralyzed normal services dedicated to the delivery of Sexual and Reproductive Health (SRH) services. In this paper, we discuss the global commitments to SRH, the impact of the EIDs on the LMICs, the failure in the delivery of SRH services, and the strategies for successful implementation of recovery plans that must address the specific and differentiated needs of women and girls in resource-poor settings.","Reprod Health","Chattu, Vijay Kumar","Yaya, Sanni","32238177"],"abstract":["This century is witnessing dramatic changes in the health needs of the world's populations. The double burden of infectious and chronic diseases constitutes major causes of morbidity and mortality. Over the last two decades, there has been a rise in infectious diseases, including the severe acute respiratory syndrome virus (SARS), the H1N1 pandemic influenza, the Ebolavirus and the Covid-19 virus. These diseases have rapidly spread across the world and have reminded us of the unprecedented connectivity that defines our modern civilization. Though some countries have made substantial progress toward improving global surveillance for emerging infectious diseases (EIDs), the vast majority of Low-and Middle-income Countries (LMICs) with fragile health systems and various system-related bottlenecks remain vulnerable to outbreaks and, as such, experience dramatic social and economic consequences when they are reported. Lessons learned from past outbreaks suggest that gender inequalities are common across a range of health issues relating to Sexual and Reproductive Health and Rights (SRHR), with women being particularly disadvantaged, partially due to the burden placed on them. Though these countries are striving to improve their health systems and be more inclusive to this vulnerable group, the national/ global outbreaks have burdened the overall system and thus paralyzed normal services dedicated to the delivery of Sexual and Reproductive Health (SRH) services. In this paper, we discuss the global commitments to SRH, the impact of the EIDs on the LMICs, the failure in the delivery of SRH services, and the strategies for successful implementation of recovery plans that must address the specific and differentiated needs of women and girls in resource-poor settings."],"journal":"Reprod Health","authors":["Chattu, Vijay Kumar","Yaya, Sanni"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238177","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1186/s12978-020-0899-y","keywords":["covid-19","ebola","emerging and re-emerging infectious diseases (eids)","gender","low- and middle-income countries (lmics)","sars","sexual and reproductive health and rights (srhrs)","sustainable developmental goals (sdgs)","women","zika"],"locations":["Ebolavirus"],"weight":0,"_version_":1666138490449952768,"score":188.73396},{"pmid":32415767,"title":"Valvular and structural heart disease management during the COVID-19 pandemic. Expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society.","text":["Valvular and structural heart disease management during the COVID-19 pandemic. Expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society.","Ongoing pandemics of SARS-CoV-2 coronavirus disease 2019 (COVID-19) represents a major challenge for healthcare. Beside the proven involvement of cardiovascular system in COVID-19, increased healthcare system resources are redirected towards handling infected patients and thus induce major changes in access to services and priorities in the management of patients with unrelated chronic cardiovascular disease. This document, created by task force involving Working Groups on Valvular Heart Disease and Cardiac Surgery as well as Association of Cardiovascular Intervention, Polish Cardiac Society proposes modifications of diagnostic pathways, principles of healthcare professionals protection and guidelines for treatment according to triage and prioritization. Valvular heart teams should continue working with utilization of telemedicine and digital technology. Diagnostic tests must be simplified or deferred to minimize potentially dangerous aerosol generating procedures such as transesophageal echocardiography or exercise imaging. Treatments for aortic stenosis and mitral regurgitation have to be offered especially in urgent indications and in patients with advanced disease and poor prognosis. Expert risk stratification is essential for triage and setting the priority lists. In any case, appropriate level of personal protection must be ensured for healthcare personnel to prevent spreading infections and preserving specialized manpower to supply for the continuing need of handling chronic serious cardiovascular disease. Importantly, as soon as the local epidemic situation improves, efforts must be made to rebuild standard opportunities for elective treatment of valvular heart disease and occluder-based therapies according to existing guidelines, thus rebuilding stat-of-the-art cardiovascular services.","Kardiol Pol","Plonska-Gosciniak, Edyta","Suwalski, Piotr","Bartus, Stanislaw","Kukulski, Tomasz","Komar, Monika","Wojakowski, Wojciech","Grygier, Marek","Pruszczyk, Piotr","Gasior, Zbigniew","Huczek, Zenon","Berger-Kucza, Adrianna","Bak, Janusz","Sorysz, Danuta","Kasprzak, Jaroslaw D","32415767"],"abstract":["Ongoing pandemics of SARS-CoV-2 coronavirus disease 2019 (COVID-19) represents a major challenge for healthcare. Beside the proven involvement of cardiovascular system in COVID-19, increased healthcare system resources are redirected towards handling infected patients and thus induce major changes in access to services and priorities in the management of patients with unrelated chronic cardiovascular disease. This document, created by task force involving Working Groups on Valvular Heart Disease and Cardiac Surgery as well as Association of Cardiovascular Intervention, Polish Cardiac Society proposes modifications of diagnostic pathways, principles of healthcare professionals protection and guidelines for treatment according to triage and prioritization. Valvular heart teams should continue working with utilization of telemedicine and digital technology. Diagnostic tests must be simplified or deferred to minimize potentially dangerous aerosol generating procedures such as transesophageal echocardiography or exercise imaging. Treatments for aortic stenosis and mitral regurgitation have to be offered especially in urgent indications and in patients with advanced disease and poor prognosis. Expert risk stratification is essential for triage and setting the priority lists. In any case, appropriate level of personal protection must be ensured for healthcare personnel to prevent spreading infections and preserving specialized manpower to supply for the continuing need of handling chronic serious cardiovascular disease. Importantly, as soon as the local epidemic situation improves, efforts must be made to rebuild standard opportunities for elective treatment of valvular heart disease and occluder-based therapies according to existing guidelines, thus rebuilding stat-of-the-art cardiovascular services."],"journal":"Kardiol Pol","authors":["Plonska-Gosciniak, Edyta","Suwalski, Piotr","Bartus, Stanislaw","Kukulski, Tomasz","Komar, Monika","Wojakowski, Wojciech","Grygier, Marek","Pruszczyk, Piotr","Gasior, Zbigniew","Huczek, Zenon","Berger-Kucza, Adrianna","Bak, Janusz","Sorysz, Danuta","Kasprzak, Jaroslaw D"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32415767","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.33963/KP.15358","locations":["Polish"],"countries":["Poland"],"countries_codes":["POL|Poland"],"topics":["Prevention"],"weight":1,"_version_":1666994545911398400,"score":167.75958},{"pmid":32304401,"pmcid":"PMC7195848","title":"Orthopaedic Surgical Selection and Inpatient Paradigms During the Coronavirus COVID-19 Pandemic.","text":["Orthopaedic Surgical Selection and Inpatient Paradigms During the Coronavirus COVID-19 Pandemic.","The Novel Coronavirus (COVID-19) pandemic, also known as SARS-CoV-2, has placed an immense strain on health care systems across the entire world. Consequently, multiple federal and state governments have placed restrictions on hospitals such as limiting \"elective surgery\" and recommending social or physical distancing. We review the literature on several areas that have been affected including surgical selection, inpatient care, and physician well-being. These areas affecting inpatient paradigms include surgical priority, physical or social distancing, file sharing for online clinical communications, and physician wellness. During this crisis, it is important that orthopaedic departments place an emphasis on personnel safety and slowing the spread of the virus, so that the department can still maintain vital functions. Physical Distancing and emerging technologies such as inpatient telemedicine and online file sharing applications can enable orthopaedic programs to still function, while attempting to protect medical staff and patients from COVID-19 spread. This literature review sought to provide evidence-based guidance to orthopaedic departments during an unprecedented time. Orthopaedic surgeons should follow the Centers for Disease Control and Prevention (CDC) guidelines, wear PPE when appropriate, have teams created utilizing physical distancing, understand the department's policy on elective surgery, and engage in routines which enhance physician wellness.","J Am Acad Orthop Surg","Massey, Patrick A","McClary, Kaylan","Zhang, Andrew S","Savoie, Felix H","Barton, R Shane","32304401"],"abstract":["The Novel Coronavirus (COVID-19) pandemic, also known as SARS-CoV-2, has placed an immense strain on health care systems across the entire world. Consequently, multiple federal and state governments have placed restrictions on hospitals such as limiting \"elective surgery\" and recommending social or physical distancing. We review the literature on several areas that have been affected including surgical selection, inpatient care, and physician well-being. These areas affecting inpatient paradigms include surgical priority, physical or social distancing, file sharing for online clinical communications, and physician wellness. During this crisis, it is important that orthopaedic departments place an emphasis on personnel safety and slowing the spread of the virus, so that the department can still maintain vital functions. Physical Distancing and emerging technologies such as inpatient telemedicine and online file sharing applications can enable orthopaedic programs to still function, while attempting to protect medical staff and patients from COVID-19 spread. This literature review sought to provide evidence-based guidance to orthopaedic departments during an unprecedented time. Orthopaedic surgeons should follow the Centers for Disease Control and Prevention (CDC) guidelines, wear PPE when appropriate, have teams created utilizing physical distancing, understand the department's policy on elective surgery, and engage in routines which enhance physician wellness."],"journal":"J Am Acad Orthop Surg","authors":["Massey, Patrick A","McClary, Kaylan","Zhang, Andrew S","Savoie, Felix H","Barton, R Shane"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32304401","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.5435/JAAOS-D-20-00360","topics":["Prevention"],"weight":1,"_version_":1666138491088535552,"score":167.62001}]}